版本:
中国

BRIEF-Galectin Therapeutics Q1 loss per share $0.15

May 15 Galectin Therapeutics Inc

* Galectin therapeutics reports 2017 first quarter financial results and provides business update

* Q1 loss per share $0.15

* As of march 31, 2017, company had $13.6 million of non-restricted cash and cash equivalents Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐